The retinoblastoma tumour suppressor in development and cancer
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro systems20,42,58–61.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [61]
In the citing paper
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
In the citing paper
“In virtually all human cancer cells, this circuit is dysregulated by either overexpression of cyclin D1, loss of p16Ink4a, the mutation of CDK4 to an Ink4-refractory state, or the loss of Rb itself (Classon and Harlow, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“RB is therefore linked directly to the intricate regulatory network that controls cell-cycle progressio”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · cited 1×
“These findings indicated that RB is a regulator of cell proliferatio”
BackgroundHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Research works printed but not linked: 4
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. W. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293–5303 (1999). · DOI
- Elliott, M. J., Dong, Y. B., Yang, H. & McMasters, K. M. E2F-1 upregulates c-Myc and p14ARF and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7, 3590–3597 (2001).
Cited by
Items 301–400 of 738
Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism
García‐Ortega, M. B., Lopez, G., Jiménez, G., Garcia-Garcia, J., Conde, V., Boulaiz, H., Carrillo, E., Perán, M., Marchal, J. A., & Garcia, M. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.11 · Cited by 36
Violetti, S. A., Fanoni, D., Provasi, M., Corti, L., Venegoni, L., & Berti, E. (2017) · Journal of Cutaneous Pathology · doi:10.1111/cup.13020 · Cited by 38
“The skin lesions are represented by different colors: the left ear nodule in orange; the right gluteal plaque in blue; the papule on the right thigh in green and the nodule on the right thigh in red genome by regulating cell cycle arrest at G1/S and G2/M.19 On 22q12, the CHK2 coding gene (CHEK2) is a cell cycle checkp…”
BackgroundG1 arrest and differentiation can occur independently of Rb family function
Wirt, S. E., Adler, A. S., Gebala, V., Weimann, J. M., Schaffer, B. E., Saddic, L., Viatour, P., Vogel, H. S., Chang, H. Y., Meissner, A., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201003048 · Cited by 37
D’Anneo, A., Augello, G., Santulli, A., Giuliano, M., Fiore, R. D., Messina, C. M., Tesoriere, G., & Vento, R. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21983 · Cited by 37
“Retinoblastoma represents the prototypic model for inherited cancers (Friend et al., 1986; Classon and Harlow, 2002) with the pivotal genetic event being the inactivation, due to mutations or deletions, of both copies of RB1 at the chromosomal locus 13q14 (Goodrich, 2006).”
BackgroundKang, D. W., Lee, S., Hwang, W. C., Lee, B. H., Choi, Y.-S., Suh, Y., Choi, K., & Min, D. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3032 · Cited by 35
PI3Kδ activates E2F1 synthesis in response to mRNA translation stress
Gnanasundram, S. V., Pyndiah, S., Daskalogianni, C., Armfield, K., Nylander, K., Wilson, J. B., & Fåhræus, R. (2017) · Nature Communications · doi:10.1038/s41467-017-02282-w · Cited by 39
“The PI3Kδ belongs, together with PI3Kα and PI3Kβ, to the class IA of the PI3K family that use phosphatidylinositol (4,5) bisphosphate (PI(4,5)P2) as a substrate to generate the lipid second messenger PI(3,4,5)P3 following tyrosine kinase receptor activation and the recruitment of the p85-type regulatory subunits in co…”
Immunotherapy in pancreatic cancer: New hope or mission impossible?
Jiang, J., Zhou, H., Ni, C., Hu, X., Mou, Y., Huang, D., & Yang, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.10.045 · Cited by 40
RB controls growth, survival, and neuronal migration in human cerebral organoids
Matsui, T. K., Nieto‐Estévez, V., Kyrychenko, S., Schneider, J. W., & Hsieh, J. (2017) · Development · doi:10.1242/dev.143636 · Cited by 38
“Since the discovery of the tumor suppressor gene RB1, many studies have demonstrated its role in regulating the G1-to-S transition in various cell types (Classon and Harlow, 2002;McClellan and Slack, 2006; Julian et al., 2016; MacPherson et al., 2003; Naser et al., 2016).”
BackgroundResultInfluentialQiu, W., Wu, J., Walsh, E. M., Zhang, Y., Chen, C. Y., Fujita, J., & Xiao, Z.-X. J. (2008) · Oncogene · doi:10.1038/onc.2008.43 · Cited by 39
Regulation of cell lineage specification by the retinoblastoma tumor suppressor
Skapek, S. X., Pan, Y.-R., & Lee, E. Y.-H. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209710 · Cited by 34
“Although they share certain biochemical properties, the proteins serve distinct functions in cell cycle regulation and the tumor suppressive effects of p107 and p130 are less clear (reviewed in Classon and Harlow, 2002; WikenheiserBrokamp, 2006).”
BackgroundDisruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Lara, M. F., García‐Escudero, R., Ruiz, S., Santos, M., Moral, M., Martínez‐Cruz, A. B., Segrelles, C., Lorz, C., & Paramio, J. M. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20376 · Cited by 37
Human retinoblastoma is not caused by known pRb‐inactivating human DNA tumor viruses
Gillison, M. L., Chen, R., Goshu, E., Rushlow, D., Chen, N., Banister, C. E., Creek, K. E., & Gallie, B. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22516 · Cited by 34
“The RB1 gene on chromosome 13q14 encodes a nuclear phosphoprotein (the tumor suppressor pRb) that plays a key regulatory role in the cell cycle check point between G1 and entry into Sphase.(2) In addition to mutations in the RB1 gene, pRb function can be abrogated by oncoproteins from several DNA tumor viruses that in…”
BackgroundInfluentialSun, H., Chang, Y., Schweers, B. A., Dyer, M. A., Zhang, X., Hayward, S. W., & Goodrich, D. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1527-1537.2006 · Cited by 38
“Rb1 loss also compromises cell-type-specific fate determination and differentiation (8).”
BackgroundDominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33
“decreased differentiation potential (Classon and Harlow 2002).”
The Intricate Interplay between Cell Cycle Regulators and Autophagy in Cancer
Ziegler, D. V., Huber, K., & Fajas, L. (2021) · Cancers · doi:10.3390/cancers14010153 · Cited by 37
“Nevertheless, in addition to E2Fs, pRB interacts with more than 200 proteins [90], including the hypoxia-inducible factor 1, that initiate the transcription of multiple genes involved in autophagy under hypoxic conditions [91].”
BackgroundCecchini, M. J., Thwaites, M. J., Talluri, S., MacDonald, J. I., Passos, D. T., Chong, J.-L., Cantalupo, P. G., Stafford, P. M., Sáenz-Robles, M. T., Francis, S. M., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01589-13 · Cited by 34
“Free E2Fs then activate a transcriptional program that drives the cell into S phase (3).”
BackgroundBerman, H. K., Gauthier, M. L., & Tlsty, T. D. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0073 · Cited by 35
Chim, C. S., Wong, K. Y., Loong, F., Lam, W. W. L., & Srivastava, G. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.05.009 · Cited by 33
Consensus transcriptional regulatory networks of coronavirus-infected human cells
Ochsner, S. A., Pillich, R., & McKenna, N. J. (2020) · Scientific Data · doi:10.1038/s41597-020-00628-6 · Cited by 39
Paternot, S., Dumont, J. E., & Roger, P. P. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0515 · Cited by 32
“variety of transcription factors (83), including Pax 8 in”
BackgroundThe RB Protein Family in Retinal Development and Retinoblastoma: New Insights from New Mouse Models
Bremner, R., Chen, D., Pacal, M., Livne‐Bar, I., & Agochiya, M. (2004) · Developmental Neuroscience · doi:10.1159/000082284 · Cited by 36
Pleiotropic constraints promote the evolution of cooperation in cellular groups
Bentley, M. A., Yates, C. A., Hein, J., Preston, G. M., & Foster, K. R. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001626 · Cited by 34
“For example, loss of function mutations in the retinoblastoma tumour suppressor gene are linked to the activation of programmed cell death (apoptosis) [36,37], while activation of ras genes— key regulators of cell proliferation—are associated with cellular senescence and cell cycle arrest [64].”
BackgroundMatsuda, S., Kominato, K., Koide‐Yoshida, S., Miyamoto, K., Isshiki, K., Tsuji, A., & Yuasa, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542936 · Cited by 32
“Previous studies indicated that Rb regulates cell proliferation by controlling the activity of various transcription factors in the nucleus (41, 42), suggesting that PCTK3 may not be able to make contact with Rb because of the differences in their subcellular localizations.”
BackgroundActivation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells
Shi, X. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1157 · Cited by 31
“It is mutated or expressed at very low levels in several tumor types, including retinoblastoma and osteosarcoma, as well as small cell lung, colon, prostate, bladder and breast carcinoma (45).”
BackgroundCyclin-dependent kinase inhibitors in malignant hematopoiesis
Schirripa, A., Sexl, V., & Kollmann, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916682 · Cited by 41
“CDK-dependent Rb phosphorylation releases Rb from E2F transcription factors and induces transcription of E2F target genes required for Sphase entry (9).”
BackgroundApoptosis triggered redistribution of caspase‐9 from cytoplasm to mitochondria
Potokar, M., Milisav, I., Kreft, M., Stenovec, M., & Zorec, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00494-0 · Cited by 33
von Willebrand, M., Zacksenhaus, E., Cheng, E., Glazer, P. M., & Halaban, R. (2003) · PubMed · Cited by 30
Avior, Y., Lezmi, E., Yanuka, D., & Benvenisty, N. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.005 · Cited by 31
“Other studies used mutations in additional murine genes alongside Rb1 to initiate retinoblastoma or model the role of Rb1 in its initiation, diverging from its manifestation in humans (Classon and Harlow, 2002; Conklin et al., 2012).”
BackgroundRetinoblastoma protein (RB) interacts with E2F3 to control terminal differentiation of Sertoli cells
Rotgers, E., Rivero‐Müller, A., Nurmio, M., Parvinen, M., Guillou, F., Huhtaniemi, I. T., Kotaja, N., Bourguiba, S., & Toppari, J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.232 · Cited by 35
DUSP 16 ablation arrests the cell cycle and induces cellular senescence
Zhang, H., Zheng, H., Mu, W., He, Z., Yang, B., Ji, Y., & Hui, L. (2015) · FEBS Journal · doi:10.1111/febs.13518 · Cited by 35
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
Boyer, M. J., & Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303064 · Cited by 36
Novel Functions for Cell Cycle Genes in Nervous System Development
McClellan, K. A., & Slack, R. S. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2980 · Cited by 33
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29
“In cell cycle regulation, Rb protein binds to E2F and arrests cell cycle progression (35).”
BackgroundA dynamic switch in Rb+/− mediated neuroendocrine tumorigenesis
Leung, S. W., Wloga, E. H., Castro, A. F., Nguyen, T., Bronson, R. T., & Yamasaki, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207457 · Cited by 29
“…ability to repress the action of the E2F/DP family of transcription factors, which act as bifunctional transcriptional switches to stimulate cell cycle progression or apoptosis, depending on the presence of environmental signals (Classon and Harlow, 2002; Trimarchi and Lees, 2002; Yamasaki, 2003).”
BackgroundRole of Mammalian Ecdysoneless in Cell Cycle Regulation
Kim, J. H., Gurumurthy, C. B., Naramura, M., Zhang, Y., Dudley, A. T., Doglio, L. T., Band, H., & Band, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030551 · Cited by 35
David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 37
Persistent Hyperplastic Primary Vitreous Due to Somatic Mosaic Deletion of the Arf Tumor Suppressor
Thornton, J. D., Swanson, D. J., Mary, M. N., Pei, D., Martin, A. C., Pounds, S. B., Goldowitz, D., & Skapek, S. X. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0765 · Cited by 30
Molecular Biology of Basal and Squamous Cell Carcinomas
Xie, J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_19 · Cited by 29
DNA markers in molecular diagnostics for hepatocellular carcinoma
Su, Y., Lin, S. Y., Song, W., & Jain, S. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.946908 · Cited by 28
Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer
Kim, N., Song, M., Kim, S., SEO, Y., Kim, Y., & Yoon, S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3262 · Cited by 30
“The crucial role of RB1 as a regulator in cell cycle progression has been intensively investigated (7-9).”
BackgroundPirkmaier, A., Dow, R., Ganiatsas, S., Waring, P., Warren, K., Thompson, A., Hendley, J., & Germain, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206488 · Cited by 29
“D-type cyclins associate with cdk4 and 6 to promote the phosphorylation of the retinoblastoma (Rb) protein (for a review see Classon and Harlow, 2002).”
BackgroundEmerging role of epigenetic therapies in cutaneous T-cell lymphomas
Zain, J. M., Kaminetzky, D., & O’Connor, O. A. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.9 · Cited by 30
Aydın, Y., Chedid, M., Chava, S. P., Williams, D. D., Liu, S., Hagedorn, C. H., Sumitran–Holgersson, S., Reiss, K., Moroz, K., Lu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10087-6 · Cited by 28
RetractedMolecular mechanisms of hyperplasia induction by human papillomavirus E7
Ueno, T., Sasaki, K., Yoshida, S., Kajitani, N., Satsuka, A., Nakamura, H., & Sakai, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209445 · Cited by 30
“The latter is considered to play a role in the transition into the G0 phase of the cell cycle and the induction of cellular differentiation (Graña et al., 1998; Lipinski and Jacks, 1999; Classon and Dyson, 2001; Classon and Harlow, 2002).”
BackgroundWang, L., Meng, Q., Jiao, Y., Xu, J.-Y., Ge, C., Zhou, J., Rosen, E. M., Wang, H., & Fan, S. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1199 · Cited by 28
“The tumor suppression function of RB is dependent, at least in part, on interactions with the E2F family of DNAbinding transcription factors (E2F).(17,18) To understand the importance of the RB/HMGB interaction, we examined whether HMGBs exhibited potential effects on RB-meditated E2F or cyclin A transcription repress…”
Nampoothiri, L. P., Neelima, P., & Rao, A. J. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60896-6 · Cited by 28
Expression of axin2 Is Regulated by the Alternative 5′-Untranslated Regions of Its mRNA
Hughes, T. A., & Brady, H. J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410806200 · Cited by 33
Retinoblastoma Protein Is Frequently Absent or Phosphorylated in Anaplastic Large-Cell Lymphoma
Rassidakis, G. Z., Lai, R. L., Herling, M., Cromwell, C. C., Schmitt-Graeff, A. H., & Medeiros, L. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63782-0 · Cited by 31
“Accumulating evidence from in vitro and in vivo studies suggests that the rb gene product, a 105-kd protein, is implicated in many cellular functions including cell proliferation, apoptosis, and differentiation.(4) The role of Rb protein as a major cell-cycle inhibitor is mediated through its interaction with the E2F…”
BackgroundSkp2 and Skp2B team up against Rb and p53.
Germain, D. (2011) · Cell Division · doi:10.1186/1747-1028-6-1 · Cited by 27
“D-type cyclins associate with cdk4 and 6 to promote the phosphorylation of the Retinoblastoma (Rb) protein (for review, [2]).”
BackgroundZhao, Q., Ma, Y., Li, Z., Zhang, K., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8835714 · Cited by 33
PROTACs in gastrointestinal cancers
Chen, Y., Yang, Q., Xu, J., Tang, L., Zhang, Y., Du, F., Zhao, Y., Wu, X., Li, M., Shen, J., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.10.012 · Cited by 30
“Eventually, cell cycle progression is facilitated by a shift from the G1 to the S phase.(172) Thus, targeting CDK4/6 can block cell cycle progression.”
BackgroundMice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Bailly‐Maitre, B., Bard-Chapeau, E. A., Luciano, F., Droin, N. M., Bruey, J., Faustin, B., Kress, C. L., Zapata, J. M., & Reed, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0850 · Cited by 29
“Gene ablation studies in mice show that interleukin (IL)-6 and tumor necrosis factor-a (TNF-a )a re important contributors to liver regeneration (7, 8), and some of their immediate downstream transcription factors have been identified as crucial regulators of the regenerative process, including signal transducers and…”
BackgroundLi, Y., Idamakanti, N., Arroyo, T., Thorne, S. H., Reid, T. R., Nichols, S. J., VanRoey, M. J., Colbern, G. T., Nguyen, N. N. M., Tam, O., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1757 · Cited by 28
Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective
Coller, H. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190014 · Cited by 34
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein
Zhang, H., Hu, L., Qiu, W., Deng, T., Zhang, Y., Bergholz, J. S., & Xiao, Z.-X. (2015) · Oncogene · doi:10.1038/onc.2015.11 · Cited by 28
The Temporal Regulation of S Phase Proteins During G1
Grant, G. D., & Cook, J. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_16 · Cited by 34
“The three pocket proteins have both overlapping and distinct roles, patterns of expression, regulation, and binding partners during the cell cycle (Classon and Harlow 2002).”
BackgroundSurvivin inhibits anti-growth effect of p53 activated by aurora B
Jung, J., Kim, T., Lee, J.-S., Oh, S.-Y., Kwak, S., Jin, X., Sohn, J., Song, M., Sohn, Y.-W., Lee, S.-Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.235 · Cited by 26
Adenovirus E1A proteins direct subcellular redistribution of Nek9, A NimA‐related kinase
Pelka, P., Scimè, A., Mandalfino, C., Joch, M., ABDULLA, P. R., & Whyte, P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20983 · Cited by 34
Claudin 13, a Member of the Claudin Family Regulated in Mouse Stress Induced Erythropoiesis
Thompson, P. D., Tipney, H., Brass, A., Noyes, H. A., Kemp, S., Naessens, J., & Tassabehji, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012667 · Cited by 30
“Another of the genes clustered with Cldn13, E2f2, has been shown to form a complex with RB1, a key player in the regulation of the G1-to-S-phase transition of the cell cycle [64] and GATA1, encouraging terminal erythroid differentiation by shutting down cell proliferation [29].”
BackgroundCell cycle regulation in hair cell development and regeneration in the mouse cochlea
Liu, Z., & Zuo, J. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6423 · Cited by 27
Ausserlechner, M. J., Obexer, P., Geley, S., & Kofler, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403729 · Cited by 32
Differential regulation of apoptotic genes by Rb in human versus mouse cells
Young, A. P., & Longmore, G. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207330 · Cited by 30
“Cyclin/cdks phosphorylate and inactivate Rb precisely at mid- to late-G1, and then Rb is dephosphorylated and activated again during exit from mitosis (Tamrakar et al., 2000; Classon and Harlow, 2002).”
BackgroundInfluentialDNA damage response in proliferating Müller glia in the mammalian retina
Nomura-Komoike, K., Saitoh, F., Komoike, Y., & Fujieda, H. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-18101 · Cited by 25
Yeh, N., Miller, J. P., Gaur, T., Capellini, T. D., Nikolich‐Žugich, J., de la Hoz, C., Selleri, L., Bromage, T. G., van Wijnen, A. J., Stein, G. S., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02431-06 · Cited by 27
“The relationship between pocket proteins and CKI is complex, with each family of proteins affecting the expression levels of the other and compensating for each other to control CDK activity (10, 11, 35, 65).”
BackgroundDifferential role of RB in response to UV and IR damage
Bosco, E. E. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki283 · Cited by 24
The Role of Lysine Methyltransferase SET7/9 in Proliferation and Cell Stress Response
Daks, A. A., Vasileva, E., Fedorova, O., Shuvalov, O. Y., & Barlev, N. A. (2022) · Life · doi:10.3390/life12030362 · Cited by 25
“In line with this, the phosphorylation of pRb required for the release of E2F1 and hence cell cycle progression was attenuated by the methylation of pRb at K810 by SET7/9 [41,62,63].”
BackgroundAcharya, P., Nègre, N., Johnston, J., Wei, Y., White, K. P., Henry, R. W., & Arnosti, D. N. (2012) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.004424 · Cited by 26
“…association Although many well-characterized targets of RB family proteins are genes involved in cell-cycle regulation and DNA replication, genes involved in other processes are also functionally regulated by these corepressors (Classon and Harlow 2002; Dimova et al. 2003; Kirienko and Fay 2007).”
BackgroundMethodInfluentialMizuarai, S., Machida, T., Kobayashi, T., Komatani, H., Itadani, H., & Kotani, H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-31 · Cited by 23
“The RB1 loss is caused by several molecular events such as point mutations, deletion, or inactivation through associating viral proteins [19].”
BackgroundOshikawa, M., Okada, K., Nakajima, K., & Ajioka, I. (2013) · Development · doi:10.1242/dev.095653 · Cited by 29
“These Rb-dependent functions are regulated in a context-specific manner (Burkhart and Sage, 2008; Chau and Wang, 2003; Classon and Harlow, 2002; Weinberg, 1995).”
BackgroundWang, X., Deng, H., Basu, I., & Zhu, L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2428 · Cited by 27
A new cancer diagnostic system based on a CDK profiling technology
Ishihara, H., Yoshida, T., Kawasaki, Y., Kobayashi, H., Yamasaki, M., Nakayama, S., Miki, E., Shohmi, K.-I., Matsushima, T., Tada, S., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.001 · Cited by 24
“This inactivation is exerted by a variety of molecules in the cascade that activates the CDK molecules (CDK2, 4, and 6), which play a role in the G1 progression of the cell cycle by phosphorylating (inactivating) the RB protein [1,2].”
BackgroundTumour-suppressor function in the nervous system
Baker, S. J., & McKinnon, P. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1297 · Cited by 31
RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1
TANG, H., Ji, F., Sun, J., Xie, Y., Xu, Y.-Y., & Yue, H.-T. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4670 · Cited by 23
“(11,12).”
Drosophila RB Proteins Repress Differentiation-Specific Genes via Two Different Mechanisms
Lee, H., Ohno, K., Voskoboynik, Y., Ragusano, L., Martinez, A., & Dimova, D. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01075-09 · Cited by 32
“The retinoblastoma protein (pRB) is a critical regulator of cell division, cell death, and differentiation in metazoans, and its activity is altered in most human tumors (9, 22, 47, 48, 60).”
Backgrounddi Pietro, M., Marra, G., Ćejka, P., Stojic, L., Menigatti, M., Cattaruzza, M. S., & Jiricny, J. (2003) · PubMed · doi:10.5167/uzh-31248 · Cited by 23
“This might be ascribed to the inactivation of pRb by the transfected E1A that brings about deregulation of E2F activity, a pivotal transcription factor acting in response to cell cycle modulators (47).”
BackgroundBhattacharya, P., & Sengupta, S. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.007 · Cited by 23
Structural Insights into the Mechanism of Phosphoregulation of the Retinoblastoma Protein
Lamber, E. P., Beuron, F., Morris, E. P., Svergun, D. I., & Mittnacht, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058463 · Cited by 24
“The retinoblastoma tumour susceptibility protein (RB1) plays an important role in regulating cell cycle progression, cell survival and differentiation [1,2].”
Backgroundp21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia
Sáiz-Ladera, C., Lara, M. F., Garin, M. I., Ruiz, S., Santos, M., Lorz, C., García‐Escudero, R., Martínez‐Fernández, M., Bravo, A., Fernández-Capetillo, Ó., et al. (2013) · Oncogene · doi:10.1038/onc.2013.417 · Cited by 24
Cdh1–APC is involved in the differentiation of neural stem cells into neurons
Yao, W., Qian, W., Zhu, C., Gui, L., Qiu, J. F., & Zhang, C. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32833312fe · Cited by 22
Pezzuto, A., Cappuzzo, F., D’Arcangelo, M., Ciccozzi, M., Navarini, L., Guerrini, S., Rícci, A., D’Ascanio, M., & Carico, E. (2020) · Anticancer Research · doi:10.21873/anticanres.14032 · Cited by 22
Uramoto, H., Hackzell, A., Wetterskog, D., Ballagi, A. E., Izumi, H., & Funa, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01228 · Cited by 24
Lee, J., Shamanna, R. A., Kulikowicz, T., Fakouri, N. B., Kim, E. W., Christiansen, L. S., Croteau, D. L., & Bohr, V. A. (2021) · Aging Cell · doi:10.1111/acel.13484 · Cited by 22
RB1 gene mutations and genetic spectrum in retinoblastoma cases
Ödemiş, D. A., Kebudi, R., Bayramova, J., Kılıç, S., Türkcan, G. K., Tunçer, Ş. B., Erdoğan, Ö. Ş., Çelik, B., Gültaslar, B. K., Bay, S. B., et al. (2023) · Medicine · doi:10.1097/md.0000000000035068 · Cited by 21
“This protein which normally regulates the cell proliferation and prevents uncontrolled cell division, acts as a tumor suppressor.[10] The effects of tumor suppressor genes on cancer were described first in retinoblastoma.”
BackgroundCummings, T. J., & Klintworth, G. K. (2006) · CRC Press eBooks · doi:10.1201/b13439-53 · Cited by 20
Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
Rekha, T. N., & Shin, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065190 · Cited by 22
Geng, Y., Liu, P., Xie, Y., Liu, Y., Zhang, X., Hou, X., & Zhang, L. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155004 · Cited by 21
High expression of TAZ indicates a poor prognosis in retinoblastoma
Zhang, Y., Xue, C., Cui, H., & Huang, Z. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0415-9 · Cited by 20
“Retinoblastoma is the most common eye cancer in children, which is caused by mutation of the RB1 gene [23–25].”
BackgroundpRb-E2F signaling in life of mesenchymal stem cells: Cell cycle, cell fate, and cell differentiation
Popov, B. V., & Ns, P. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.007 · Cited by 21
Zaharieva, M. M., Konstantinov, S., Pilicheva, B., Karaivanova, M., & Berger, M. R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.022 · Cited by 20
Obexer, P., Hagenbuchner, J., Rupp, M., Salvador, C., Holzner, M., Deutsch, M., Porto, V., Kofler, R., Unterkircher, T., & Ausserlechner, M. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051441 · Cited by 23
TIS21/BTG2/PC3 inhibits interleukin-6 expression via downregulation of STAT3 pathway
Quy, L. N., Choi, Y. W., Kim, Y. H., Chwae, Y., Park, T. J., & Lim, I. K. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.024 · Cited by 21
Yuasa, K., Suzue, K., Nagahama, M., Matsuda, Y., & Tsuji, A. (2007) · Gene · doi:10.1016/j.gene.2007.07.028 · Cited by 19
The Birt-Hogg-Dube tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis
Gaur, K., Li, J., Wang, D., Dutta, P., Yan, S.-J., Tsurumi, A., Land, H., Wu, G., & Li, W. X. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds428 · Cited by 19
“Because the misexpression and deregulation of components of the protein synthesis machinery in cancer cells have been extensively documented (28), together with the knowledge that ribosome biogenesis is tightly coupled to proper cell-cycle progression (29,30), it is now becoming evident that disruption of key steps in…”
BackgroundDhuppar, S., & Mazumder, A. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1482136 · Cited by 19
Das, K. C., & Ravi, D. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978426 · Cited by 20
“D-type D-type cyclins associate with cdk4 or cdk6 to form complexes whose major substrate is retinoblastoma protein (Rb) and related proteins, p107 and p130 (3, 18).”
A cancer-specific transcriptional signature in human neoplasia
Nicassio, F., Bianchi, F., Capra, M., Vecchi, M., Confalonieri, S., Bianchi, M., Pajalunga, D., Crescenzi, M., Bonapace, I. M., & Fiore, P. P. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24862 · Cited by 22
Mouse Models of Human Familial Cancer Syndromes
Ward, J. M., & Devor-Henneman, D. E. (2004) · Toxicologic Pathology · doi:10.1080/01926230490424680 · Cited by 23
“The homozygous null state may be embryo-lethal but has never been found The homozygous null state is frequently embryo-lethal Relatively small number of subjects for study except for some syndromes Virtually limitless number of subjects for study Ethicolegal constraints regarding experimental study methods or therapie…”
BackgroundMa, Q., Hu, Q., Xu, R., Zhen, X.-C., & Wang, G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.48 · Cited by 20
Huang, Q., Hou, S., Zhu, X., & Liu, S. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-1798-y · Cited by 18
Metadata
- Authors
- Classon, M., & Harlow, E.
- Affiliations
- Harvard University (US)
- ORCID
- Classon, Marie
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 910-917
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998492363
- Cited by
- 738
- References
- 133
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 28 · 2016: 24 · 2015: 32 · 2014: 35 · 2013: 23 · 2012: 42
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma protein, RB1, tumour suppressor, cell proliferation, cell differentiation, cell survival, Rb family proteins, protein redundancy, knockout mice, development (biology), cancer
- MeSH terms
- Animals, Cell Division, Humans, Nuclear Proteins, Phenotype, Phosphoproteins, Proteins, Retinoblastoma, Signal Transduction, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.